24.07.20 ijBio Portfolio
Infojet ClubPharm Involved.
$1,000,000 on 12.06.20 Changes for 24.07.20:
AstraZeneca (AZN) $51,3 $55,8 (+8.8%) $108,800
Inovio (INO) $13,2 $21,9 (+66%) $166,400
Moderna (MRNA) $61,5 $73,2 (+19%) $119,000
Abbot (ABT) $88,5 $99 (+11.9%) $111,900
Gilead (GILD) $72,5 $73,6 (+1.5%) $101,500
Adaptive (ADPT) $42,2 $36,3 (-14%) $86,000
CytoDyn (CYDY) $3,12 $5,4 (+73.1%) $173,100
AbbVie (ABBV) $92,2 $97,1 (+5.3%) $105,300
Arcus (RCUS) $27,3 $22,15 (-18.9%) $81,900
Sorrento (SRNE) $4,6 $7,3 (+58.7%) $158,700
At close 24.07.20 = $1,212,600 (-4,2%)
per million dollars at 10% per share.
during the week 17-24.06.2020: -7.9%
At close 24.07.20 = $1,212,600 (-4,2%)
At close 23.07.20 = $1,265,400 (-2.7%)
At close 22.07.20 = $1,300,500 (-1%)
At close 21.07.20 = $1,314,300 (-1.9%)
At close 20.07.20 = $1,340,000 (+1.8%)
during the week 10-17.06.2020: +7.6%
At close 17.07.20= $1,316,800 (+4.7%)
for a month from June 12: +22,5%
during the week 03-10.06.2020: +0.5%
during the week 26-03.06.2020: -4.5%
during the week 19-26.06.2020:+21%
during the week 12-19.06 +5,5%
12.06.20 = $1,000,000
Global Communication Platforms Portfoilio
--
Portfolio News:
Can Inovio’s COVID-19 Vaccine Make up Lost Ground? Analyst Weighs In
Moderna says patent ruling not to affect COVID-19 vaccine development
Upcoming Phase 2 COVID-19 Trial Marks Key Milestone for Sorrento (SRNE); Analyst Says ‘Buy’
Even as Indy Goes Autonomous, the Race to True Self-Driving Has Been Long
Why Moderna, Vaxart, Inovio, and BioNTech Stocks Dropped Today
Stocks Showing Improved Relative Strength: Abbott Laboratories
Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers
AbbVie Proves Masterful at Playing Drug Patent Game
Trump signs executive order aimed at lowering drug prices
Covid-19 Vaccine Makers Could Be Heroes. But Not if the Price Tag Is Too High.
Sorrento Therapeutics to Buy Its Coronavirus Vaccine Development Partner
Statement from Moderna on Patent Trial and Appeal Board (PTAB) Ruling
Why Sorrento Therapeutics Stock Slipped Today
Moderna Lost a Patent Case and the Stock Is Slipping
Coronavirus latest: Friday, July 24
Moderna and Peloton Make the Grade: The Week in Analysts' Reports
Dow Jones Resilient Despite Intel Sell-Off; 5 Top Growth Stocks Test Key Support Level
Will Coronavirus Woes Impact Gilead's (GILD) Q2 Earnings?
Tiny Arbutus Biopharma Wins Patent Litigation Fight with COVID-19 Vaccine Implications
Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for
Vaccine checkup: Where pharmaceutical companies stand in the fight against COVID-19
With help but without the assistance of Yahoo Finance
Advertise With Us